Literature DB >> 24677398

Shedding light on the asparaginase galaxy.

Carmelo Rizzari1.   

Abstract

In this issue of Blood, Tong et al have reported that therapeutic drug monitoring (TDM) of asparaginase (ASP) activity levels in plasma may be an important tool for the optimization of its therapeutic effects in pediatric acute lymphoblastic leukemia (ALL).

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24677398     DOI： 10.1182/blood-2014-02-553040

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  3 in total

Review 1.  Asparaginase pharmacokinetics and implications of therapeutic drug monitoring.

Authors:  Barbara Asselin; Carmelo Rizzari
Journal:  Leuk Lymphoma       Date:  2015-03-11

2.  Expression of a recombinant bacterial L-asparaginase in human cells.

Authors:  Raquel Caminha Dantas; Ludmilla Freire Caetano; Ariany Lima Sousa Torres; Matheus Soares Alves; Emanuelly Thays Muniz Figueiredo Silva; Louhanna Pinheiro Rodrigues Teixeira; Daniel Câmara Teixeira; Renato de Azevedo Moreira; Marcela Helena Gambim Fonseca; Saul Gaudêncio Neto; Leonardo Tondello Martins; Gilvan Pessoa Furtado; Kaio Cesar Simiano Tavares
Journal:  BMC Res Notes       Date:  2019-12-05

3.  Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase.

Authors:  Kristen M Lorentz; Stephan Kontos; Giacomo Diaceri; Hugues Henry; Jeffrey A Hubbell
Journal:  Sci Adv       Date:  2015-07-17       Impact factor: 14.136
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.